BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25581585)

  • 1. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
    Arits A; Nelemans P; Kelleners-Smeets N
    Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
    Nijsten T
    Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
    [No Abstract]   [Full Text] [Related]  

  • 3. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal.
    Lecluse LL; Spuls PI
    Br J Dermatol; 2015 Jan; 172(1):8-10. PubMed ID: 25581584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pigmentation on photodynamic therapy.
    Apalla Z; Lallas A; Sotiriou E; Ioannides D
    Lancet Oncol; 2013 Aug; 14(9):e339-40. PubMed ID: 23896270
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of pigmentation on photodynamic therapy - Authors' reply.
    Arits A; Kelleners-Smeets NW
    Lancet Oncol; 2013 Aug; 14(9):e340. PubMed ID: 23896273
    [No Abstract]   [Full Text] [Related]  

  • 7. Treating basal-cell carcinoma in a real life setting.
    Dummer R
    Lancet Oncol; 2013 Jun; 14(7):572-3. PubMed ID: 23683749
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
    Arits AH; Spoorenberg E; Mosterd K; Nelemans P; Kelleners-Smeets NW; Essers BA
    Br J Dermatol; 2014 Dec; 171(6):1501-7. PubMed ID: 24749843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
    Roozeboom MH; van Kleef L; Arits AH; Mosterd K; Winnepenninckx VJ; van Marion AM; Nelemans PJ; Kelleners-Smeets NW
    J Am Acad Dermatol; 2015 Jul; 73(1):93-8. PubMed ID: 25935596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
    Devirgiliis V; Panasiti V; Curzio M; Gobbi S; Rossi M; Roberti V; Calvieri S
    Dermatol Online J; 2008 Feb; 14(2):25. PubMed ID: 18700128
    [No Abstract]   [Full Text] [Related]  

  • 11. Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.
    Roozeboom MH; Nelemans PJ; Mosterd K; Steijlen PM; Arits AH; Kelleners-Smeets NW
    Br J Dermatol; 2015 Mar; 172(3):739-45. PubMed ID: 25066012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
    Sotiriou E; Apalla Z; Ioannides D
    Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
    [No Abstract]   [Full Text] [Related]  

  • 13. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
    Jansen MHE; Mosterd K; Arits AHMM; Roozeboom MH; Sommer A; Essers BAB; van Pelt HPA; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
    J Invest Dermatol; 2018 Mar; 138(3):527-533. PubMed ID: 29045820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroepithelioma of Pinkus: poor response to topical photodynamic therapy.
    Park MY; Kim YC
    Eur J Dermatol; 2010; 20(1):133-4. PubMed ID: 19919909
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-Aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
    Christensen E
    Stomatologija; 2013; 15(3):ii. PubMed ID: 24511763
    [No Abstract]   [Full Text] [Related]  

  • 16. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
    Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
    Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
    van Delft LCJ; Nelemans PJ; Jansen MHE; Arits AHMM; Roozeboom MH; Hamid MA; Mosterd K; Kelleners-Smeets NWJ
    J Am Acad Dermatol; 2019 Apr; 80(4):1022-1028. PubMed ID: 30582993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Topical Treatments for Basal Cell Carcinoma.
    Shaw FM; Weinstock MA
    J Invest Dermatol; 2018 Mar; 138(3):484-486. PubMed ID: 29395168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular basal cell carcinoma: when in doubt, cut it out.
    Brownell I
    J Drugs Dermatol; 2007 Dec; 6(12):1245-6. PubMed ID: 18189068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison in real clinical practice of methyl aminolevulinate photodynamic therapy and surgery for small superficial basal cell carcinoma: 3-year recurrence rates and cosmetic outcomes.
    Sebaratnam DF; Venugopal SS; Murrell DF
    J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):117-8. PubMed ID: 20456551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.